Plant-Based Vaccines

Plants can churn out lots of recombinant proteins, and these proteins aren’t contaminated with animal proteins. Plant-based vaccines are recombinant protein subunit vaccines. The challenges facing plant-based vaccine development include technical, regulatory and economic aspects and public perception. In the technical challenges it is very difficult to select a plant system where it grows under optimized conditions to minimize the environmental risks. Ideally, the plant species choice used to produce the selected antigen should applicable for oral drug delivery in an edible vaccine form. To date, the most advanced human vaccine projects have successfully completed phase I clinical trials, & animal vaccine projects have given promising data in early phase trials targeting the specific animal species.

 

  • Production of Plant based Vaccine
  • Biotherapeutics of Plant Vaccine
  • Plant based Vaccine against Virus
  • Molecular level of Plant based Vaccine
  • Direct Gene Delivery Method
  • Disadvantages of Plant Based Vaccines
  • Methods to Increase the Efficiency of Gene Delivery

Related Conference of Plant-Based Vaccines

December 06-07, 2018

International Congress on Vaccines & Immunology

Amsterdam, Netherlands
March 18-19, 2019

33rdAnnual Vaccines & Vaccination Congress

New York, USA
March 18-19, 2019

35th World Vaccines & Immunization Congress

Novotel Brisbane, Australia
March 21-22, 2019

32nd International Conference on Vaccines and Immunization

Hotel Holiday Inn, Aurelia Rome, Italy
August 12-13, 2019

34th World Congress on Vaccines and Immunization

Auckland,Newzealand

Plant-Based Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in